Clinical Trials Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. May 7, 2017; 23(17): 3133-3141
Published online May 7, 2017. doi: 10.3748/wjg.v23.i17.3133
Table 4 Relative enhancement ratio in the hepatocyte phase in the five stages of hepatic fibrosis
StageREh (mean ± SD)Minimum valueMaximum value
S0 (n = 16)0.450 ± 0.1950.1290.698
S1 (n = 15)0.460 ± 0.1760.1780.715
S2 (n = 21)0.542 ± 0.2040.2291.006
S3 (n = 9)0.364 ± 0.1770.3230.621
S4 (n = 15)0.411 ± 0.1840.1840.836